Kiniksa Pharmaceuticals International annual operating margin
2021
2022
2023
2024
2025
Kiniksa Pharmaceuticals International Operating Margin Growth & History (KNSA)
Kiniksa Pharmaceuticals International's operating margin was 11.40% for fiscal 2025.
View full Kiniksa Pharmaceuticals International company overviewKiniksa Pharmaceuticals International annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 11.40% | +22.17 pp |
| 2024 | 2024-12-31 | −10.78% | −1.45 pp |
| 2023 | 2023-12-31 | −9.32% | −13.76 pp |
| 2022 | 2022-12-31 | 4.44% | +410.82 pp |
| 2021 | 2021-12-31 | −406.38% | — |
Kiniksa Pharmaceuticals International quarterly operating margin
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 11.16% | −1.69 pp |
| Q1 2026 | 2026-03-31 | 13.66% | +4.03 pp |
| Q4 2025 | 2025-12-31 | 9.78% | +25.53 pp |
| Q3 2025 | 2025-09-30 | 13.28% | +21.89 pp |
| Q2 2025 | 2025-06-30 | 12.86% | +12.97 pp |
| Q1 2025 | 2025-03-31 | 9.63% | +30.35 pp |
| Q4 2024 | 2024-12-31 | −15.75% | −15.85 pp |
| Q3 2024 | 2024-09-30 | −8.61% | +7.69 pp |
| Q2 2024 | 2024-06-30 | −0.11% | +4.31 pp |
| Q1 2024 | 2024-03-31 | −20.71% | +2.44 pp |
| Q4 2023 | 2023-12-31 | 0.10% | −9.67 pp |
| Q3 2023 | 2023-09-30 | −16.30% | −63.12 pp |
| Q2 2023 | 2023-06-30 | −4.41% | +67.39 pp |
| Q1 2023 | 2023-03-31 | −23.16% | +49.29 pp |
| Q4 2022 | 2022-12-31 | 9.77% | — |
| Q3 2022 | 2022-09-30 | 46.82% | +300.37 pp |
| Q2 2022 | 2022-06-30 | −71.81% | +454.61 pp |
| Q1 2022 | 2022-03-31 | −72.44% | — |
| Q3 2021 | 2021-09-30 | −253.55% | — |
| Q2 2021 | 2021-06-30 | −526.41% | — |
Kiniksa Pharmaceuticals International operating margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Kiniksa Pharmaceuticals International's operating margin increased from −406.38% to 11.40%, a change of +417.78 percentage points. The latest reported quarter, Q2 2026, shows 11.16%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kiniksa Pharmaceuticals International source filings ↗